Nurse Practitioner, Family · Natick, MA
NPI
1538494786
Since 2009
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
34 Franconia Ave
Natick, MA, 01760
Phone (508) 650-0979
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$92K
794 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Susan L Neuber prescribed most often to Medicare patients was Doxycycline Hyclate, with 107 prescriptions and refills. In total Susan L Neuber wrote 794 Medicare prescriptions that cost $92K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-10-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Doxycycline Hyclate Generic | 107 | 107 | 37 | $2,597 |
| Azithromycin Generic | 89 | 89 | 21 | $3,268 |
| Cefuroxime Cefuroxime Axetil | 72 | 72 | 21 | $3,739 |
| Atovaquone-Proguanil Hcl Atovaquone/Proguanil Hcl | 65 | 68 | 20 | $17K |
| Atovaquone Generic | 53 | 54 | 14 | $26K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 52 | 52 | 12 | $698 |
| Nystatin Generic | 44 | 49 | Under 11 | $2,439 |
| Tetracycline Hcl Generic | 39 | 39 | 15 | $4,382 |
| Cefdinir Generic | 35 | 37 | Under 11 | $1,982 |
| Minocycline Hcl Generic | 33 | 41 | Under 11 | $1,042 |
| Fluconazole Generic | 32 | 32 | Under 11 | $208 |
| Gabapentin Generic | 21 | 21 | Under 11 | $219 |
| Rifampin Generic | 20 | 20 | Under 11 | $589 |
| Clarithromycin Generic | 15 | 15 | Under 11 | $496 |
| Celecoxib Generic | 14 | 14 | Under 11 | $459 |
Brand drugs: 24 claims; generic drugs: 770 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Susan L Neuber were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.